Timothy C. Moses

BioGenetics, Inc. is engaged in the business of antimicrobials and biocides. It operates through two business segments: Antimicrobial and Biostatic and Biopharmaceutical Antibiotic and Antiviral product. The Antimicrobial and Biostatic segments products are used within the manufacturer's use products (MUP), retail, and institutional markets, which are sold through Nova BioGenetics, Inc. or its subsidiary, Nova Specialty Chemical, Inc. The Biopharmaceutical Antibiotic and Antiviral segment products are marketed through Nova BioPharmaceutical, Inc. The company was founded on April 23, 2001 and is headquartered in Sandy Springs, GA.